Cited by 80Epilepsy research and treatmentSmoking Behavior and CessationVagus Nerve Stimulation Research

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Nicotine as an Antiepileptic Agent in ADNFLE: An N‐of‐One Study

Open access

Abstract

Summary: Purpose: To test nicotine patch treatment for a patient with a defined mutation for autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) whose seizures were refractory to standard antiepileptic therapy. Methods: Open and double‐blind trials of nicotine patches in an “n‐of‐one” study. The double‐blind trial comprised periods during which either placebo or nicotine patches were each used for three periods of 2 weeks, randomized in a double‐blind manner. Results: In an open study, nicotine patches reduced seizures from 1.65 ± 2.36 to 0.01 ± 0.0 seizures per day (p < 0.0001). In a double‐blinded placebo‐controlled phase, the average frequency of seizures on nicotine versus placebo was 0 ± 0 versus 0.56 ± 1.14 seizures per day (p < 0.0001). Conclusions: Nicotine patches may be of benefit to some individuals with ADNFLE.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1528-1157.2003.58102.x-i1

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Metadata

Authors
Willoughby, J. O., Pope, K. J., & Eaton, V.
Affiliations
Flinders University (AU)
Venue
Epilepsia
Publisher
Wiley
Published
2003-08-12
Volume
44
Issue
9
Pages
1238-1240
ISSN
  • 0013-9580 (ISSN-L)
  • 1528-1167
OpenAlex
W1985571774
Cited by
80
References
6
Citations by year
2026: 2 · 2025: 4 · 2024: 6 · 2023: 2 · 2022: 1 · 2021: 3 · 2020: 8 · 2019: 2 · 2018: 4 · 2017: 1 · 2016: 4 · 2015: 4 · 2014: 5 · 2013: 1 · 2012: 5
FWCI
1.22
Type
journal article
Language
en
Open access
Locations
  • Epilepsia (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
  • Life Sciences › Neuroscience › Neurology › Vagus Nerve Stimulation Research
Keywords
nicotine, nicotine patch, autosomal dominant nocturnal frontal lobe epilepsy, drug-resistant epilepsy, anticonvulsant therapy, seizure frequency, open-label extension
MeSH terms
Administration, Cutaneous, Adult, Anticonvulsants, Double-Blind Method, Female, Humans, Mutation, Nicotine, Epilepsy, Frontal Lobe

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review